Indications |
Oral Acute bronchospasm Adult: Initially, 2.5 or 3 mg tid increased to 5 mg tid if necessary; as modified-release tablet: 7.5 mg bid. Child: 75 mcg/kg tid; usual dose for >7 yr: 2.5 mg bid-tid. Inhalation Acute bronchospasm Adult: As metered dose inhaler: 250 mcg or 500 mcg every 4-6 hrs. Max: 2000 mcg/24hr. As nebuliser: 5-10 mg inhaled 2-4 times or 1-2mg/hr given as a 0.01% nebuliser solution in sodium chloride 0.9%. Child: As metered dose inhaler: 250 mcg or 500 mcg every 4-6 hrs. Max: 2000 mcg/24hr. As nebuliser: 2-5 mg inhaled 2-4 times. Parenteral Severe bronchospasm Adult: 250-500 mcg SC, IM or slow IV Inj up to 4 times daily, or by IV infusion 3-5 mcg/ml run at a infusion rate of 0.5-1 mL/min. Child: >2 yrs: 10 mcg/kg by SC, IM or slow IV injection. Max total dose: 300mcg. Intravenous Uncomplicated premature labour Adult: 5 mcg/min for 20 min, increased every 20 min in steps of 2.5 mcg/min until contractions have ceased (usually 10 mcg/min sufficient), continue for 1 hr then decrease every 20 min in steps of 2.5 mcg/min to lowest dose that maintains suppression, continue at this level for 12 hrs. Max: 20mcg/min. Switch to oral at 2.5-10mg every 4-6hr if indicated and tolerated. Continue as long as needed to prolong pregnancy. |
Contraindications |
Hypersensitivity to sympathomimetics. Any condition of mother or foetus in which prolongation of pregnancy is dangerous. |
Warnings / Precautions |
Arrhythmias, hyperthyroidism, hypertension, diabetes, myocardial insufficiency, history of seizures, heart disease. |
Adverse Reactions |
Fine skeletal muscle tremor esp hands, dizziness, anxiety, flushes, sweating, nausea, vomiting, lethargy, tinnitus, tachycardia, palpitations, muscle cramps, headache, paradoxical bronchospasm. IV: Transient hyperglycemia, transient hypokaelemia. Potentially Fatal: (IV): MI, pulmonary oedema, ketoacidosis. |
Overdose Reactions |
Headache, anxiety, tremor, nausea, palpitations, hypotension, tachycardia and arrhythmia, hypokaelaemia, hyperglycaemia and lactic acidosis. Supportive and symptomatic treatment; use β-blockers (eg. metoprolol) cautiously for treatment of arrhythmias; IV loop diuretic for treatment of pulmonary oedema; IV propranolol 1 -2mg, if increased tendency to uterine bleed during Caesarean section. |
Drug Interactions |
Antagonised effects of β-blockers. Increased risk of hypokaelemia with xanthine derivatives, corticosteriods and diuretics; increased risk of arrhythmias with inhaled anaesthetics, sympathomimetics. See Below for More terbutaline Drug Interactions |
Mechanism of Actions |
Terbutaline is a direct-acting sympathomimetic which relaxes bronchial smooth muscle by selective action on β2 receptors. It also decreases uterine contractility. Onset: Inhalation: 5 min; Oral: 30 min. Duration: Inhalation: 3-4 hr; Oral: 8 hr. Absorption: Absorbed from the GI tract. Distribution: Some amounts cross the placenta and appear in breast milk. Half-life: 3 to 4 hr. Metabolism: 60% of absorbed dose undergoes first-pass metabolism by sulphate conjugation in the liver and gut wall. Excretion: Via the urine partly as inactive conjugates and partly as unchanged drug. |
Administration |
May be taken with or without food. |
ATC Classification |
R03AC03 - terbutaline ; Belongs to the class of adrenergic inhalants, selective beta-2-adrenoreceptor agonists. Used in the treatment of obstructive airway diseases. R03CC03 - terbutaline ; Belongs to the class of adrenergics for systemic use, selective beta-2-adrenoreceptor agonists. Used in the treatment of obstructive airway diseases. |
Available As |
|
Terbutaline
Post Review about Terbutaline Click here to cancel reply.
Terbutaline Containing Brands
Terbutaline is used in following diseases
Drug - Drug Interactions of Terbutaline
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.